Clinical trial
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the…
NCT00221026 · Mallinckrodt, Industry · Completed
Key facts
| NCT number | NCT00221026 |
|---|---|
| Title | Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease |
| Official title | A Multicenter, Open-Label, Study of Extracorporeal Photoimmune Therapy With UVADEX in the Treatment of Patients With Moderately Active Crohn's Disease Who Are Refractory or Intolerant to Immunosuppressants and/or Anti-TNF Agents |
| Lead sponsor | Mallinckrodt, Industry |
| Collaborators | ICON plc Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug, Procedure |
| Interventions | Methoxsalen +ECP, Extracorporeal Photopheresis |
| Enrollment | 25 |
| Start date | Dec 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 19, 2016 |
| Countries | Austria, Belgium, Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: